{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    6,
    8,
    17,
    20,
    25,
    26,
    29,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 0.8,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 1.3 - Schedule of Activities (SoA)",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Added footnote regarding procedures specific to US screening sites."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 4.2 - Scientific Rationale for Study Design",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Updated the duration of zinc inhibitory effects to align with other protocol sections."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3.1",
        "affectedSection": "Section 8 - Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Introduced US-specific provision allowing sites to perform only screening procedures without subsequent study procedures."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3.1",
        "reasonText": "Clarify study procedures across different US sites to facilitate participant recruitment and lessen participant inconvenience.",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3.1",
        "reasonText": "Align the number of days for zinc discontinuation effects with other mentions in the protocol.",
        "category": "Administrative",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3.1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Footnote stating procedures specific to screening sites (only in the US) detailed in Section 8",
        "summary": "Added SoA footnote for US screening sites."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3.1",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc.",
        "afterText": "inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc.",
        "summary": "Changed zinc turnover duration from 30 to 21 days."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3.1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "afterText": "Addition of text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
        "summary": "Added provision for US-only screening-only sites."
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 2,
      "changeCount": 3
    }
  }
}